- Investing Ideas
- Australian Healthcare Undervalued over 20% based on DCF
Australian Healthcare Undervalued over 20% based on DCF
Results
5
Companies which are undervalued more than 20% based on the Discounted Cash Flow valuation.
5 companies
Ramsay Health Care
Market Cap: AU$8.7b
Owns and operates hospitals in Australia and internationally.
RHC
AU$37.64
7D
3.9%
1Y
1.2%
Ansell
Market Cap: AU$4.0b
Designs, sources, develops, manufactures, distributes, and sells hand and body protection solutions in the Asia Pacific, Europe, the Middle East, Africa, Latin America, the Caribbean, and North America.
ANN
AU$28.38
7D
4.2%
1Y
-9.0%
PolyNovo
Market Cap: AU$718.5m
Designs, manufactures, and sells biodegradable medical devices in Australia, New Zealand, the United States, the United Kingdom, Ireland, Singapore, India, and Hong Kong.
PNV
AU$1.04
7D
-5.9%
1Y
-22.7%
Alcidion Group
Market Cap: AU$134.3m
Engages in the development and licensing of healthcare software products in Australia, New Zealand, and the United Kingdom.
ALC
AU$0.10
7D
-9.1%
1Y
8.7%
SomnoMed
Market Cap: AU$129.3m
SomnoMed Limited, together with its subsidiaries, produce and sells devices for the oral treatment of sleep related disorders in the Asia Pacific region, North America, and Europe.
SOM
AU$0.59
7D
-1.7%
1Y
0%